Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Beta Drugs Ltd

Beta Drugs Ltd share price and stock overview

Beta Drugs Ltd (NSE: BETA, BSE: 535022) operates in the Pharmaceuticals - Indian - Bulk Drugs sector. The stock has an ISIN of INE351Y01019 and a face value of Rs 10. As of 26 July 2026, it trades at Rs (2,315.60) with a market capitalisation of Rs 2412.98 crore. Figures are live and subject to change.

Beta Drugs Ltd

Pharmaceuticals - Indian - Bulk Drugs
NSE BSE
2,315.60 38.40 (1.69%) upARrowC
As on: 26-Jul-2026 , 11:48 AM
Market Cap(₹Cr) 2412.98
Book Value(₹Cr) 143.7932191
BSE Code : 535022 NSE Symbol : BETA EPS(TTM) : 15.39 ISIN Demat : INE351Y01019 P/E(TTM) : 150.46 Face Value(₹) : 10 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

76,210.95

Todday's Low

75,474.43

Open at

75,708.19

Previous Close

76,391.39

Volumes

Avg Price

-331.62

Historical Performance

News

20 Jul 26
Beta Drugs consolidated net profit rises 35.04% in the June 2026 quarter
Net profit of Beta Drugs rose 35.04% to Rs 15.80 crore in the quarter ended June 2026 as against Rs 11.
20 Jul 26
Beta Drugs standalone net profit rises 40.19% in the June 2026 quarter
Net profit of Beta Drugs rose 40.19% to Rs 5.93 crore in the quarter ended June 2026 as against Rs 4.
16 Jul 26
Beta Drugs to hold board meeting
Beta Drugs will hold a meeting of the Board of Directors of the Company on 20 July 2026.
14 May 26
Beta Drugs consolidated net profit rises 0.22% in the March 2026 quarter
Net profit of Beta Drugs rose 0.22% to Rs 9.05 crore in the quarter ended March 2026 as against Rs 9.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
24-07-26 2258.00 2340.00 2242.20 2315.60 19164 3690 43937868.70 23767.45
23-07-26 2335.00 2399.00 2250.00 2277.20 25376 4453 58992996.90 23869.60
22-07-26 2478.40 2498.80 2272.00 2314.70 63720 9467 149412097.80 23996.25
21-07-26 2437.00 2495.40 2383.90 2478.40 51162 6543 125217233.50 24187.70
20-07-26 2299.00 2674.00 2299.00 2439.40 515803 50477 1295291141.20 24238.50
17-07-26 2280.00 2389.00 2206.80 2229.10 42504 8527 96978934.60 24334.30
16-07-26 2320.00 2338.70 2241.70 2260.70 13039 2021 29597362.00 24072.75
15-07-26 2354.70 2362.70 2277.10 2305.00 18575 2731 43026564.70 24078.50
14-07-26 2361.90 2370.00 2272.00 2310.20 22065 3693 50970372.80 24052.05
13-07-26 2370.00 2424.30 2322.10 2347.80 48772 6253 115832918.00 24211.00
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

2412.98

PE Ratio

150.46

PB Ratio

16.10

Dividend Yield

0

ROE

15.30

ROCE

15.57

Book Value (₹)

143.7932191

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6551392 59.10 6551392 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6551392 59.10 6551392 5
Total ShareHolding for Promoter & Group 6551392 59.10 6551392 5
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 113166 1.02 113166 6
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 691196 6.24 691196 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 804362 7.26 804362 14
plus  Non Institution
Bodies Corporate 868650 7.84 868650 66
Clearing Members 2444 0.02 2444 9
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 104707 0.94 104707 255
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 48712 0.44 48712 146
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1270367 11.46 1270367 11
Individuals holding nominal share capital up to Rs. 1 lakh 1423650 12.84 1423650 6839
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3730118 33.65 3730118 7340
Total Public Shareholding 4534480 40.90 4534480 7354
Total of Promoter & Public ShareHolding 11085872 100.00 11085872 7359
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 11085872 100.00 11085872 7359

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Net Sales362.36295.71227.11183.84116.12
OPM (%)16.9816.4918.0818.6613.74
OP61.5448.7541.0634.3015.95
Other Income6.441.360.750.760.50
PBIDT76.4761.3653.8843.4525.24
INTEREST6.992.822.411.902.42
PBDT69.4858.5451.4741.5622.82
PBT52.4048.7541.0634.3015.95
EO-4.570.000.000.000.00
PBT after EO56.9748.7541.0634.3015.95
TAXES14.5512.3210.349.474.23
PAT42.4236.4430.7224.8311.72
EPS42.0237.9031.9525.8212.20
Raw Material48.5156.6948.6152.3352.15
Power and Fuel1.461.521.511.522.03
Employee Cost9.368.759.998.659.37
Other Manufacturing Expenses0.440.290.600.640.88
Selling and Administration Expenses11.179.368.926.786.68
Miscellaneous Expenses0.300.240.260.170.39
Revenue (Growth %) 22.5430.2123.5458.3127.88
PBIDT (Growth %)24.6413.8723.9972.1437.81
PAT (Growth %) 16.4218.6223.73111.7624.53
PBIDT (Margin %)21.1020.7523.7223.6421.74
PAT (Margin %) 11.7112.3213.5313.5110.10

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital 10.099.619.619.619.619.61
Reserves Total 118.94106.4086.6467.8553.8046.83
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds129.03116.0196.2577.4663.4156.44
Secured Loans 10.555.685.956.845.198.88
Unsecured Loans 117.000.000.000.000.000.03
Total Debt127.555.685.956.845.198.91
Other Liabilities6.163.182.592.441.820.86
Total Liabilities262.74124.87104.7986.7470.4266.21
APPLICATION OF FUNDS :
Gross Block 89.5265.1259.8453.8643.1541.54
Less : Accumulated Depreciation 36.0428.6425.0719.8115.149.87
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 53.4836.4834.7734.0528.0131.67
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress0.000.000.000.001.900.08
Producing Properties0.000.000.000.000.000.00
Investments 5.775.776.556.546.546.12
Current Assets, Loans & Advances
Inventories 27.4421.9413.668.477.706.10
Sundry Debtors 48.5850.4943.5931.3520.8120.91
Cash and Bank Balance141.9927.2017.7915.588.274.16
Loans and Advances 22.3014.059.957.356.786.00
Total Current Assets240.31113.6885.0062.7643.5537.17
Less : Current Liabilities and Provisions
Current Liabilities 54.0843.7426.3122.2215.2315.42
Provisions -0.301.872.941.940.570.56
Total Current Liabilities & Provisions53.7845.6129.2524.1615.8115.98
Net Current Assets186.5368.0755.7538.6027.7421.19
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets1.100.810.890.600.370.00
Deferred Tax Liability0.000.000.000.000.000.03
Net Deferred Tax1.100.810.890.600.37-0.03
Other Assets15.8613.736.836.945.867.18
Total Assets262.74124.86104.7986.7470.4266.21
Contingent Liabilities1.681.001.000.000.000.00

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Financing Activities -4.341.27-2.19-0.76118.20
Investing Activities -3.15-12.72-5.82-11.02-21.46
Net Cash Flow 4.107.312.219.40114.79
Operating Activities 11.6018.7610.2321.1918.04

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
26th Mar 2025BonusBonus (Ratio =1:20)

Board of Directors

Chairman & Chief Executive Officer
RB
Rahul Batra
Chairman & Managing Director
Executive
Functional Directors
VB
Varun Batra
Joint Managing Director
MD
BS
Balwant Singh
Whole-time Director
WTD
AS
Ashutosh Shukla
Whole-time Director
WTD
AM
Ajay Mahipal
Non Executive Director
Exec.
Independent Directors
RP
Rohit Parti
Independent Director
Ind.
MK
Manmohan Khanna
Independent Director
Ind.
SS
Sanjay Sehgal
Independent Director
Ind.
LKW
Lalit Kumar Watts
Independent Director
Ind.
MJ
Monica Jain
Independent Director
Ind.
Other Officials
RB
Rajni Brar
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Beta Drugs Ltd? −

Beta Drugs Ltd trades on NSE under BETA and on BSE under code 535022. The ISIN is INE351Y01019 and the face value is Rs 10.

What is the share price of Beta Drugs Ltd today? +

As of 26 July 2026, Beta Drugs Ltd trades at Rs 2,315.60, a change of 38.40 (1.69%) on the day. Prices are live and subject to change.

What is the market capitalisation of Beta Drugs Ltd? +

As of 26 July 2026, Beta Drugs Ltd has a market cap of about Rs 2412.98 crore. This figure is live and moves with the share price.

Is Beta Drugs Ltd profitable? +

In March 2025, Beta Drugs Ltd reported a profit after tax of Rs 42.42 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Beta Drugs Ltd? +

: As of 26 July 2026, the PE (TTM) for Beta Drugs Ltd is 150.46 and the price-to-book ratio is 16.10. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Beta Drugs Ltd pay a dividend? +

As of 26 July 2026, the dividend yield for Beta Drugs Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Beta Drugs Ltd? +

As of the latest disclosed pattern, promoters hold 59.10% of Beta Drugs Ltd. Public shareholding is 40.90%, including mutual funds at 0.00% and foreign institutional investors at 1.02%.

What were the latest annual financials of Beta Drugs Ltd? +

In March 2025, Beta Drugs Ltd reported net sales of Rs 362.36 crore, revenue growth of 22.54%, and earnings per share of Rs 42.02.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web